181 related articles for article (PubMed ID: 36612274)
1. Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review.
Sommariva A; Valle M; Gelmini R; Tonello M; Carboni F; De Manzoni G; Sorrentino L; Pasqual EM; Bacchetti S; Sassaroli C; Di Giorgio A; Framarini M; Marrelli D; Casella F; Federici O
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612274
[TBL] [Abstract][Full Text] [Related]
2. Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence.
Pasqual EM; Londero AP; Robella M; Tonello M; Sommariva A; De Simone M; Bacchetti S; Baiocchi G; Asero S; Coccolini F; De Cian F; Guaglio M; Cinquegrana A; Cenzi C; Scaringi S; Macrì A
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765565
[TBL] [Abstract][Full Text] [Related]
3. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
4. Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.
Eftimie MA; Potlog G; Alexandrescu ST
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837456
[TBL] [Abstract][Full Text] [Related]
5. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
7. An Asian Tertiary Centre's Early Experience with Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis.
Le Linn Y; Seo CJ; Wong JSM; Ong CJ; Chia CS
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):175-180. PubMed ID: 37359940
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis.
Shaltiel T; Solomon D; Pletcher ER; Golas BJ; Magge DR; Sarpel U; Labow DM; Cohen NA
Surg Endosc; 2022 Aug; 36(8):6153-6161. PubMed ID: 35080674
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.
Mercier F; Jeremie G; Alyami M; Delphine V; Vahan K; Pascal R; Sylvie I; Guillaume P; Olivier G
Surg Endosc; 2020 Nov; 34(11):4916-4923. PubMed ID: 31792692
[TBL] [Abstract][Full Text] [Related]
10. The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Ortega J; Orfanelli T; Levine E; Konstantinidis IT
Chin Clin Oncol; 2023 Apr; 12(2):16. PubMed ID: 36946185
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic cytoreductive surgery and HIPEC in LAMN with small volume of peritoneal disease: a valuable option of treatment for good patient-related experience measures (PREMs).
Cusumano C; Carrere S; Bouillin A; Nougaret S; Khellaf L; Quénet F; Sgarbura O
Surg Endosc; 2022 Jul; 36(7):4757-4763. PubMed ID: 34845545
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'.
Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F;
Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy.
Salti GI; Naffouje SA
Surg Endosc; 2019 Jan; 33(1):52-57. PubMed ID: 29926165
[TBL] [Abstract][Full Text] [Related]
15. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis: Improved Short-term Outcomes Revealed Through Propensity Score Matching Analysis.
Bortoli N; Tonello M; Pizzolato E; Cenzi C; Pilati P; Sommariva A
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38224418
[TBL] [Abstract][Full Text] [Related]
17. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
[TBL] [Abstract][Full Text] [Related]
19. Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile?
Narasimhan V; Cheung F; Waters P; Peacock O; Warrier S; Lynch C; Michael M; Ramsay R; Heriot A
Surgeon; 2020 Oct; 18(5):287-294. PubMed ID: 31848069
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit.
Flood MP; Waters PS; Soucisse M; Ramsay R; Michael M; McCormick JJ; Warrier S; Heriot A
Langenbecks Arch Surg; 2021 Dec; 406(8):2807-2815. PubMed ID: 34495403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
